Tourette syndrome

Amazing landscapes of Appenzell with impressive rock formations and beautiful lakes
Biotech

Emalex eyes potential Tourette approval after phase 3 win

When continued on ecopipam, 41.9% of children had their symptoms relapse, significantly lower than the 68.1% rate seen in children given placebo.
Darren Incorvaia Feb 25, 2025 1:18pm
brain art

Struggling Relmada pays $3M for Tourette's asset from Asarina

Feb 7, 2025 11:00am
Soccer ball flying into a net scoring a goal

Noema ticks off phase 2a Tourette win for ex-Roche molecule

Oct 17, 2024 9:35am
end of the road road block shut down closed blocked

Asarina to close after efforts to partner Tourette's drug fail

Jul 24, 2024 10:32am
money bills fundraise

Tourette-focused Emalex rakes in $250M series D

Nov 3, 2022 7:00am